At the news
? NEUTRALIMPACT 2/10 144 filed Nov 3, 2026 at 10:15 ET
Vanina de Verneuil, an officer of Vir Biotechnology, filed a Form 144 notice of intent to sell 2,407 shares of common stock, valued at approximately $26,718 based on the filing date price. The shares were acquired through restricted stock vesting on November 1, 2026. The proposed sale is small relative to the company's $2.0B market cap and appears to be a routine transaction to cover tax withholding or diversify holdings.
- Officer Vanina de Verneuil filed Form 144 to sell 2,407 shares of Vir Biotechnology common stock.
- Estimated aggregate value of the proposed sale is $26,717.70.
- Shares were acquired on November 1, 2026 via restricted stock vesting from the issuer.
- The sale is planned for execution on or after November 3, 2026 on Nasdaq.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access